Attitudes Toward Cognitive Enhancement: The Role of Metaphor and Context

REFERENCES

• Aikins, R. D. 2011. Academic performance enhancement: A qualitative study of the perceptions and habits of prescription stimulant–using college students. Journal of College Student Development 52(5): 560–576. doi: 10.1353/csd.2011.0064.
   Web of Science ®Google Scholar
• Appel, J. M. 2008. When the boss turns pusher: A proposal for employee protections in the age of cosmetic neurology. Journal of Medical Ethics 34(8): 616–618. doi: 10.1136/jme.2007.022723.
   PubMed Web of Science ®Google Scholar
• Austin, D. S. 2013. Killing them softly: Neuroscience reveals how brain cells die from law school stress and how neural self-hacking can optimize cognitive performance. Loyola Law Review 59: 791–859.
   Google Scholar
• Babcock, Q., and T. Byrne. 2000. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 49(3): 143–145. doi: 10.1080/07448480009596296.
   PubMed Web of Science ®Google Scholar
• Banjo, O. C., R. Nadler, and P. B. Reiner. 2010. Physician attitudes towards pharmacological cognitive enhancement: Safety concerns are paramount. PLoS One 5(12): e14322. doi: 10.1371/journal.pone.0014322.
   PubMed Web of Science ®Google Scholar
• Bell, S., B. Partridge, J. Lucke, and W. Hall. 2013. Australian University Students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics 6(1): 197–205. doi: 10.1007/s12152-012-9153-9.
   Web of Science ®Google Scholar
• Bergström, L. S., and N. Lynöe. 2008. Enhancing concentration, mood and memory in healthy individuals: An empirical study of attitudes among general practitioners and the general population. Scandinavian Journal of Public Health 36(5): 532–537. doi: 10.1177/1403494807087558.
   PubMed Web of Science ®Google Scholar
• Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: Methods, ethics, regulatory challenges. Science and Engineering Ethics 15(3): 311–341. doi: 10.1007/s11948-009-9142-5.
   PubMed Web of Science ®Google Scholar
• Brand, R., W. Wolff, and M. Ziegler. 2016. Drugs as instruments: Describing and testing a behavioral approach to the study of neuroenhancement. Frontiers in Psychology 7: 1226. doi: 10.3389/fpsyg.2016.01226.
   PubMed Web of Science ®Google Scholar
• Brignell, C. M., J. Rosenthal, and H. V. Curran. 2007. Pharmacological manipulations of arousal and memory for emotional material: Effects of a single dose of methylphenidate or lorazepam. Journal of Psychopharmacology 21(7): 673–683. doi: 10.1177/0269881107077351.
   PubMed Web of Science ®Google Scholar
• Brühl, A. B., and B. J. Sahakian. 2016. Drugs, games, and devices for enhancing cognition: Implications for work and society. Annals of the New York Academy of Sciences 1369(1): 195–217. doi: 10.1111/nyas.13040.
   PubMedGoogle Scholar
• Buhrmester, M., T. Kwang, and S. D. Gosling. 2011. Amazon’s mechanical Turk: A new source of inexpensive, yet high-quality, data? Perspectives on Psychological Science 6(1): 3–5. doi: 10.1177/1745691610393980.
   Web of Science ®Google Scholar
• Caballero, J., R. L. Ownby, J. A. Rey, and K. A. Clauson. 2016. Cognitive and performance enhancing medication use to improve performance in poker. Journal of Gambling Studies 32(3): 835–845. doi: 10.1007/s10899-015-9576-4.
   PubMed Web of Science ®Google Scholar
• Cakic, V. 2009. Smart drugs for cognitive enhancement: Ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 35(10): 611–615. doi: 10.1136/jme.2009.030882.
   PubMed Web of Science ®Google Scholar
• Caviola, L., and N. S. Faber. 2015. Pills or push-ups? Effectiveness and public perception of pharmacological and non-pharmacological cognitive enhancement. Frontiers in Psychology 6: 1852.
   PubMed Web of Science ®Google Scholar
• Chandler, J. A., and A. M. Dodek. 2016. Cognitive enhancement in the courtroom. In Cognitive enhancement: Ethical and policy implications in international perspectives, eds. Fabrice Jotterand, and Veljko Dubljevic, 329–345. Oxford: Oxford University Press.
   Google Scholar
• Chatterjee, A. 2004. Cosmetic neurology: The controversy over enhancing movement, mentation, and mood. Neurology 63(6): 968–974.
   PubMed Web of Science ®Google Scholar
• Chatterjee, A. 2006. The promise and predicament of cosmetic neurology. Journal of Medical Ethics 32(2): 110–113.
   PubMed Web of Science ®Google Scholar
• Chatterjee, A. 2008. Framing pains, pills, and professors. Expositions 2(2): 139–146.
   Google Scholar
• Chatterjee, A. 2017. Grounding Ethics from below: CRISPR-cas9 and Genetic Modification. The Neuroethics Blog. 2017. http://www.theneuroethicsblog.com/2017/07/grounding-ethics-from-below-crispr-cas9.html.
   Google Scholar
• Clewis, R. R. 2017. Does Kantian ethics condone mood and cognitive enhancement? Neuroethics 10(3): 349–361. doi: 10.1007/s12152-017-9302-2.
   Web of Science ®Google Scholar
• Davis, N. 2017. A taxonomy of harms inherent in cognitive enhancement. Frontiers in Human Neuroscience 11: 63.
   PubMed Web of Science ®Google Scholar
• Desantis, A. D., and A. C. Hane. 2010. Adderall is definitely not a drug: Justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 45(1–2): 31–46. doi: 10.3109/10826080902858334.
   PubMed Web of Science ®Google Scholar
• Dietz, P., H. Striegel, A. G. Franke, K. Lieb, P. Simon, and R. Ulrich. 2013. Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33(1): 44–50. doi: 10.1002/phar.1166.
   Google Scholar
• Dijkstra, A. M., and M. Schuijff. 2016. Public opinions about human enhancement can enhance the expert-only debate: A review study. Public Understanding of Science 25(5): 588–602. doi: 10.1177/0963662514566748.
   PubMed Web of Science ®Google Scholar
• Dodge, T., K. J. Williams, M. Marzell, and R. Turrisi. 2012. Judging cheaters: Is substance misuse viewed similarly in the athletic and academic domains? Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 26(3): 678–682. doi: 10.1037/a0027872.
   PubMed Web of Science ®Google Scholar
• Dubljević, V. 2013. Prohibition or coffee shops: Regulation of amphetamine and methylphenidate for enhancement use by healthy adults. The American Journal of Bioethics: AJOB 13(7): 23–33. doi: 10.1080/15265161.2013.794875.
   PubMed Web of Science ®Google Scholar
• Dubljević, V., S. Sattler, and É. Racine. 2014. Cognitive enhancement and academic misconduct: A study exploring their frequency and relationship. Ethics & Behavior 24(5): 408–420. doi: 10.1080/10508422.2013.869747.
   Web of Science ®Google Scholar
• Emanuel, R. M., S. L. Frellsen, K. J. Kashima, S. M. Sanguino, F. S. Sierles, and C. J. Lazarus. 2013. Cognitive enhancement drug use among future physicians: Findings from a multi-institutional census of medical students. Journal of General Internal Medicine 28(8): 1028–1034. doi: 10.1007/s11606-012-2249-4.
   PubMed Web of Science ®Google Scholar
• Fitz, N. S., R. Nadler, P. Manogaran, E. W. J. Chong, and P. B. Reiner. 2013. Public attitudes toward cognitive enhancement. Neuroethics 7(2): 173–188. doi: 10.1007/s12152-013-9190-z.
   Web of Science ®Google Scholar
• Forlini, C., and E. Racine. 2009. Autonomy and coercion in academic ‘cognitive enhancement’ using methylphenidate: Perspectives of key stakeholders. Neuroethics 2(3): 163–177. doi: 10.1007/s12152-009-9043-y.
   Web of Science ®Google Scholar
• Forlini, C., and E. Racine. 2012. Stakeholder perspectives and reactions to ‘academic’ cognitive enhancement: Unsuspected meaning of ambivalence and analogies. Public Understanding of Science 21(5): 606–625.
   PubMed Web of Science ®Google Scholar
• Forlini, C., J. Schildmann, P. Roser, R. Beranek, and J. Vollmann. 2015. Knowledge, experiences and views of german university students toward neuroenhancement: An empirical-ethical analysis. Neuroethics 8(2): 83–92. doi: 10.1007/s12152-014-9218-z.
   Web of Science ®Google Scholar
• Franke, A. G., C. Bagusat, P. Dietz, I. Hoffmann, P. Simon, R. Ulrich, and K. Lieb. 2013. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Medicine 11: 102.
   Google Scholar
• Franke, A. G., C. Bonertz, M. Christmann, S. Engeser, and K. Lieb. 2012. Attitudes toward cognitive enhancement in users and nonusers of stimulants for cognitive enhancement: A pilot study. AJOB Primary Research 3(1): 48–57. doi: 10.1080/21507716.2011.608411.
   Google Scholar
• Franke, A. G., and K. Lieb. 2013. Pharmacological neuroenhancement: Substances and epidemiology. In Cognitive enhancement: An interdisciplinary perspective, ed. E. Hildt and A. G. Franke, 17–27. Dordrecht, Netherlands: Springer.
   Google Scholar
• Fukuyama, F. 2002. Our posthuman future: Consequences of the biotechnology revolution. New York, NY: Farrar, Straus and Giroux.
   Google Scholar
• Garnier-Dykstra, L. M., K. M. Caldeira, K. B. Vincent, K. E. O’Grady, and A. M. Arria. 2012. Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health 60(3): 226–234. doi: 10.1080/07448481.2011.589876.
   PubMed Web of Science ®Google Scholar
• Goodman, R. 2010. Cognitive enhancement, cheating, and accomplishment. Kennedy Institute of Ethics Journal 20(2): 145–160.
   PubMed Web of Science ®Google Scholar
• Greely, H., B. Sahakian, J. Harris, R. C. Kessler, M. Gazzaniga, P. Campbell, and M. J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456(7223): 702–705. doi: 10.1038/456702a.
   PubMed Web of Science ®Google Scholar
• Green, P. E., and V. R. Rao. 1970. Rating scales and information recovery. How many scales and response categories to use? Journal of Marketing 34(3): 33. doi: 10.2307/1249817.
   Web of Science ®Google Scholar
• Hamilton, R., S. Messing, and A. Chatterjee. 2011. Rethinking the thinking cap: Ethics of neural enhancement using noninvasive brain stimulation. Neurology 76(2): 187–193. doi: 10.1212/WNL.0b013e318205d50d.
   PubMed Web of Science ®Google Scholar
• Hotze, T. D., K. Shah, E. E. Anderson, M. K. Wynia. 2011. Doctor, would you prescribe a pill to help me …? A national survey of physicians on using medicine for human enhancement. The American Journal of Bioethics 11(1): 3–13. doi: 10.1080/15265161.2011.534957.
   PubMed Web of Science ®Google Scholar
• Hyman, S. E. 2011. Cognitive enhancement: Promises and perils. Neuron 69(4): 595–598. doi: 10.1016/j.neuron.2011.02.012.
   PubMed Web of Science ®Google Scholar
• Kass, L. R. 2003. Ageless bodies, happy souls: Biotechnology and the pursuit of perfection. New Atlantis 1: 9–28.
   Google Scholar
• Kayser, B., A. Mauron, and A. Miah. 2007. Current anti-doping policy: A critical appraisal. BMC Medical Ethics 8: 2. doi: 10.1186/1472-6939-8-2.
   PubMedGoogle Scholar
• Klayman, A. 2018. Take your pills. Film. Scotts Valley, CA, USA: Netflix.
   Google Scholar
• Lucke, J., B. Partridge, C. Forlini, and E. Racine. 2015. Using neuropharmaceuticals for cognitive enhancement: Policy and regulatory issues. In Handbook of neuroethics, 1085–1100. Dordrecht, Netherlands: Springer.
   Google Scholar
• Maier, L. J., E. Liakoni, J. Schildmann, M. P. Schaub, and M. E. Liechti. 2015. Swiss university students’ attitudes toward pharmacological cognitive enhancement. PLoS One 10(12): e0144402. doi: 10.1371/journal.pone.0144402.
   PubMed Web of Science ®Google Scholar
• Maslen, H., F. S. de Sio, and N. Faber. 2015. With cognitive enhancement comes great responsibility? In Responsible innovation 2, eds. Koops BJ., Oosterlaken I., Romijn H., Swierstra T., van den Hoven J. 121–138. Cham, Switzerland: Springer.
   Google Scholar
• Norman, G. 2010. Likert scales, levels of measurement and the ‘laws’ of statistics. Advances in Health Sciences Education 15(5): 625–632. doi: 10.1007/s10459-010-9222-y.
   PubMed Web of Science ®Google Scholar
• Partridge, B., S. Bell, J. Lucke, and W. Hall. 2013. Australian University students’ attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety. Drug and Alcohol Review 32(3): 295–302. doi: 10.1111/dar.12005.
   PubMed Web of Science ®Google Scholar
• Partridge, B., J. Lucke, and W. Hall. 2012. A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults. AJOB Primary Research 3(4): 81–86. doi: 10.1080/21507716.2012.720639.
   Google Scholar
• Peer, E., J. Vosgerau, and A. Acquisti. 2014. Reputation as a sufficient condition for data quality on amazon mechanical Turk. Behavior Research Methods 46(4): 1023–1031. doi: 10.3758/s13428-013-0434-y.
   PubMed Web of Science ®Google Scholar
• Pitman, R. K., K. M. Sanders, R. M. Zusman, A. R. Healy, F. Cheema, N. B. Lasko, L. Cahill, and S. P. Orr. 2002. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry 51(2): 189–192. doi: 10.1016/S0006-3223(01)01279-3.
   PubMed Web of Science ®Google Scholar
• President’s Council on Bioethics (U.S.). 2003. Beyond therapy: Biotechnology and the pursuit of happiness. New York, NY: Harper Perennial.
   Google Scholar
• Ray, K. S. 2016. Not just ‘Study Drugs’ for the rich: Stimulants as moral tools for creating opportunities for socially disadvantaged students. The American Journal of Bioethics: AJOB 16(6): 29–38. doi: 10.1080/15265161.2016.1170231.
   PubMed Web of Science ®Google Scholar
• Ross, J., L. Irani, M. S. Silberman, A. Zaldivar, and B. Tomlinson. 2010. Who are the crowdworkers?: Shifting demographics in Mechanical Turk. In: Conference on Human Factors in Computing Systems - Proceedings, Atlanta, April 10–15 2010, 2863–2872. New York, NY: ACM.
   Google Scholar
• Sabini, J., and J. Monterosso. 2005. Judgments of the fairness of using performance enhancing drugs. Ethics & Behavior 15(1): 81–94. doi: 10.1207/s15327019eb1501_6.
   PubMed Web of Science ®Google Scholar
• Sahakian, B., and S. Morein-Zamir. 2007. Professor's little helper. Nature 450(7173): 1157–1159. doi: 10.1038/4501157a.
   PubMed Web of Science ®Google Scholar
• Sattler, S., C. Forlini, E. Racine, and C. Sauer. 2013a. Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS One 8(8): e71452. doi: 10.1371/journal.pone.0071452.
   PubMed Web of Science ®Google Scholar
• Sattler, S., C. Sauer, G. Mehlkop, and P. Graeff. 2013b. The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS One 8(7): e68821. doi: 10.1371/journal.pone.0068821.
   PubMed Web of Science ®Google Scholar
• Savulescu, J., B. Foddy, and M. Clayton. 2004. Why we should allow performance enhancing drugs in sport. British Journal of Sports Medicine 38(6): 666–670. doi: 10.1136/bjsm.2003.005249.
   PubMed Web of Science ®Google Scholar
• Schaefer, G. O., G. Kahane, and J. Savulescu. 2014. Autonomy and enhancement. Neuroethics 7: 123–136. doi: 10.1007/s12152-013-9189-5.
   PubMed Web of Science ®Google Scholar
• Schelle, K. J., N. Faulmüller, L. Caviola, and M. Hewstone. 2014. Attitudes toward pharmacological cognitive enhancement-a review. Frontiers in Systems Neuroscience 8: 53.
   PubMedGoogle Scholar
• Scheske, C., and S. Schnall. 2012. The ethics of ‘Smart Drugs’: Moral judgments about healthy people’s use of cognitive-enhancing drugs. Basic and Applied Social Psychology 34(6): 508–515. doi: 10.1080/01973533.2012.711692.
   Web of Science ®Google Scholar
• Singh, I., I. Bard, and J. Jackson. 2014. Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One 9(10): e105969. doi: 10.1371/journal.pone.0105969.
   PubMed Web of Science ®Google Scholar
• Sullivan, G. M., and A. R. Artino. Jr. 2013. Analyzing and interpreting data from Likert-type scales. Journal of Graduate Medical Education 5(4): 541–542. doi: 10.4300/JGME-5-4-18.
   PubMedGoogle Scholar
• Thibodeau, P., J. L. McClelland, and L. Boroditsky. 2009. When a bad metaphor may not be a victimless crime: The role of metaphor in social policy. In Proceedings of the 31st annual conference of the cognitive science society, eds. N. A. Taatgen and H. van Rijn, 809–814. 29 July - 1 August 2009, Amsterdam, Netherlands. Austin, TX: Cognitive Science Society.
   Google Scholar
• Whetstine, L. M. 2015. Cognitive enhancement: Treating or cheating? Seminars in Pediatric Neurology 22(3): 172–176. doi: 10.1016/j.spen.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Winder, R., and J. Borrill. 1998. Fuels for memory: The role of oxygen and glucose in memory enhancement. Psychopharmacology 136(4): 349–356. doi: 10.1007/s002130050577.
   PubMed Web of Science ®Google Scholar
• Wolpe, P. R. 2002. Treatment, enhancement, and the ethics of neurotherapeutics. Brain and Cognition 50(3): 387–395.
   PubMed Web of Science ®Google Scholar